维持阶段老年精神分裂症复发的危险因素:一个匹配的病例对照研究
Biqi Zu1, Ting Wang1, Chunying Pan1
1School of Nursing, Dalian University, 116001 Dalian, Liaoning, China.
Alpha psychiatry
|May 12, 2025
概括
不定期服用药物,运动量低,生活中负面事件增加老年精神分裂症患者的复发风险. 良好的家庭照顾和充足的睡眠减少了这种风险,有助于预防复发.
科学领域:
- 老年精神病学是一门精神病学专业.
- 临床心理学 临床心理学
- 流行病学 流行病学
背景情况:
- 精神分裂症影响老年人群,需要研究在维持治疗期间预防复发.
- 识别特定的风险因素对于改善患者的治疗结果和生活质量至关重要.
研究的目的:
- 调查在维持阶段治疗期间老年精神分裂症患者复发的独立风险因素.
- 为这个人口群体制定有针对性的复发预防策略提供见解.
主要方法:
- 对225名在维持期治疗中的老年精神分裂症患者进行了调查.
- 使用多变量非条件物流回归和ROC曲线分析来确定风险因素及其预测值.
主要成果:
- 复发的独立风险因素包括不规则的药物状态,低运动频率和负面的生活事件.
- 确定的保护因素是家庭照顾和足够的睡眠时间.
- 这些因素对复发的综合预测值很高 (AUC:0.908).
结论:
- 服药,运动,家庭支持,生活事件管理和睡眠对于预防老年精神分裂症患者复发至关重要.
- 为有效预防复发,建议采用解决这些因素的整体方法.
相关概念视频
Psychological and Sociocultural Causes of Schizophrenia
37
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
37
Psychosis: Goals of Pharmacotherapy
96
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
96
Biological Causes of Schizophrenia
26
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
26
Psychosis and Antipsychotic Drugs: Overview
156
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
156
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
285
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
285
Drug Therapy
30
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
30


